Cargando…

Management of the primary malignant mediastinal germ cell tumors: experience with 54 patients

BACKGROUND: Primary malignant mediastinal germ cell tumor (PMMGCT) is rare and sometimes the prognosis of the patients with PMMGCT is not very satisfactory. METHODS: A total of 54 patients with PMMGCT in a follow-up from 1990 to 2009. We evaluated the role of the surgical treatment and the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Wang, Zhou, Peng, Zhong-Min, Yu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996080/
https://www.ncbi.nlm.nih.gov/pubmed/24552239
http://dx.doi.org/10.1186/1746-1596-9-33
_version_ 1782312987182235648
author Liu, Ying
Wang, Zhou
Peng, Zhong-Min
Yu, Yang
author_facet Liu, Ying
Wang, Zhou
Peng, Zhong-Min
Yu, Yang
author_sort Liu, Ying
collection PubMed
description BACKGROUND: Primary malignant mediastinal germ cell tumor (PMMGCT) is rare and sometimes the prognosis of the patients with PMMGCT is not very satisfactory. METHODS: A total of 54 patients with PMMGCT in a follow-up from 1990 to 2009. We evaluated the role of the surgical treatment and the effect of multimodality treatment strategy for patients with PMMGCT. RESULTS: Fifty-two patients underwent surgical resections, while the other two patients just received chemoradiotherapy. Among the 52 patients, 28 cases received preoperative adjuvant therapy and 24 cases underwent surgery as initial treatment; 30 cases with complete resections, 18 cases with partial resections and 4 cases with only biopsies. There was no perioperative mortality. Histopathologic results revealed 18 cases of seminomas and 36 cases of nonseminomatous germ cell tumors (NSGCT). The last follow-up showed that 17 patients were alive, including 11 patients with seminoma and 6 patients with NSGCT. The 5-year overall survival rate of patients with seminomas was 87.7%. The 3-year and 5-year overall survival rates of patients with NSGCT were 47.4% and 23.0%, respectively. CONCLUSIONS: It could be concluded that a complete surgical resection of PMMGCT after chemoradiotherapy showed favorable long-term survival. Patients with pure seminomas have a better prognosis compared with that with NSGCT. VIRTUAL SLIDES: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1676987232116837.
format Online
Article
Text
id pubmed-3996080
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39960802014-04-24 Management of the primary malignant mediastinal germ cell tumors: experience with 54 patients Liu, Ying Wang, Zhou Peng, Zhong-Min Yu, Yang Diagn Pathol Research BACKGROUND: Primary malignant mediastinal germ cell tumor (PMMGCT) is rare and sometimes the prognosis of the patients with PMMGCT is not very satisfactory. METHODS: A total of 54 patients with PMMGCT in a follow-up from 1990 to 2009. We evaluated the role of the surgical treatment and the effect of multimodality treatment strategy for patients with PMMGCT. RESULTS: Fifty-two patients underwent surgical resections, while the other two patients just received chemoradiotherapy. Among the 52 patients, 28 cases received preoperative adjuvant therapy and 24 cases underwent surgery as initial treatment; 30 cases with complete resections, 18 cases with partial resections and 4 cases with only biopsies. There was no perioperative mortality. Histopathologic results revealed 18 cases of seminomas and 36 cases of nonseminomatous germ cell tumors (NSGCT). The last follow-up showed that 17 patients were alive, including 11 patients with seminoma and 6 patients with NSGCT. The 5-year overall survival rate of patients with seminomas was 87.7%. The 3-year and 5-year overall survival rates of patients with NSGCT were 47.4% and 23.0%, respectively. CONCLUSIONS: It could be concluded that a complete surgical resection of PMMGCT after chemoradiotherapy showed favorable long-term survival. Patients with pure seminomas have a better prognosis compared with that with NSGCT. VIRTUAL SLIDES: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1676987232116837. BioMed Central 2014-02-19 /pmc/articles/PMC3996080/ /pubmed/24552239 http://dx.doi.org/10.1186/1746-1596-9-33 Text en Copyright © 2014 Liu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liu, Ying
Wang, Zhou
Peng, Zhong-Min
Yu, Yang
Management of the primary malignant mediastinal germ cell tumors: experience with 54 patients
title Management of the primary malignant mediastinal germ cell tumors: experience with 54 patients
title_full Management of the primary malignant mediastinal germ cell tumors: experience with 54 patients
title_fullStr Management of the primary malignant mediastinal germ cell tumors: experience with 54 patients
title_full_unstemmed Management of the primary malignant mediastinal germ cell tumors: experience with 54 patients
title_short Management of the primary malignant mediastinal germ cell tumors: experience with 54 patients
title_sort management of the primary malignant mediastinal germ cell tumors: experience with 54 patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996080/
https://www.ncbi.nlm.nih.gov/pubmed/24552239
http://dx.doi.org/10.1186/1746-1596-9-33
work_keys_str_mv AT liuying managementoftheprimarymalignantmediastinalgermcelltumorsexperiencewith54patients
AT wangzhou managementoftheprimarymalignantmediastinalgermcelltumorsexperiencewith54patients
AT pengzhongmin managementoftheprimarymalignantmediastinalgermcelltumorsexperiencewith54patients
AT yuyang managementoftheprimarymalignantmediastinalgermcelltumorsexperiencewith54patients